Se Habla Español

The Global Regenerative Medicine Market Size is Expected to Reach 5.60 Billion USD by 2025


By Soraya Khineche

It was announced earlier this month that the global Regenerative Medicine market size is expected to reach 5.60 billion USD by 2025. 

This substantial growth projection, along with a large increase in government-backed investments in Regenerative Medicine research is, in large part, due to the rising prevalence of chronic diseases and genetic disorders globally. With all this monetary support going towards Regenerative Medicine research, the number of companies focusing on its development has increased significantly over the last few years. As a result, there is an influx of clinical trials, new innovative treatment centers, and the development of advanced RM technologies across the globe. 

Adipose-derived stem cells (ADSCs) are also gaining demand as a new cell source in Regenerative Medicine therapies as they can be differentiated into a variety of different cell lineages. These stem cell therapies can offer the following key benefits for your physical health and well being:

  • Reverse inflammation
  • Regulate the immune system
  • Re-establish cell-to-cell communication
  • Replace damaged cells
  • Regenerate normal blood flow

Dr. Todd Malan is considered one of the true pioneers of ASDC procedures in the USA. In October of 2009, he was the first U.S. physician to utilize adipose or fat-derived stem cells for soft tissue reconstruction. Dr. Malan has been pivotal in developing safe protocols for stem cell harvesting and deployment for Regenerative Medicine and has trained hundreds of physicians worldwide in the safe and effective use of adipose-derived stem cells. 

The Center For Regenerative Cell Medicine

Led by Dr. Todd Malan, the Center for Regenerative Medicine in Scottsdale, AZ was the first medical facility in the U.S. to offer patients stem cell therapies that have been developed and used throughout Europe, Asia and many countries around the globe. We are currently a leading provider of advanced techniques and remain on the leading edge of this evolving approach to treating a chronic disease that has had no cure.

Our stem cell therapies have been used to treat the effects of injury, chronic disease, systemic disease and other conditions that have a degenerative impact on tissue function.

For more information on treatment options for chronic and genetic diseases, please contact The Center for Regenerative Cell Medicine at 480-845-0446 or visit to schedule a consultation. 

*Note: For the investigational use of Adipose-Derived Stem Cells (ADSC’s) for clinical research and deployment.